93 related articles for article (PubMed ID: 7132504)
1. [Head and neck cancers. What's new in clinical oncology for the practicing ENT physician?].
Schwab W; Feuerbach S; Schmid L; Langhammer H; Schmeisser KJ; Bauer R; Rupp N; Pabst HW; Breit A; Lindner H; Fink U; Berdel WE
Laryngol Rhinol Otol (Stuttg); 1982 Aug; 61(8):417-37. PubMed ID: 7132504
[TBL] [Abstract][Full Text] [Related]
2. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.
Krempien RC; Grehn C; Haag C; Straulino A; Hensley FW; Kotrikova B; Hofele C; Debus J; Harms W
Brachytherapy; 2005; 4(2):154-62. PubMed ID: 15893270
[TBL] [Abstract][Full Text] [Related]
3. Gallium-67 scanning in the evaluation of therapy of malignant tumors of the head and neck.
Higashi T; Kashima I; Shimura K; Nakamura K; Sakurai S
J Nucl Med; 1977 Mar; 18(3):243-9. PubMed ID: 839270
[TBL] [Abstract][Full Text] [Related]
4. [Development of treatments for head and neck squamous cell carcinomas].
Tsukuda M
Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():85-96. PubMed ID: 10410663
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapeutic management of locally advanced head and neck cancer.
Laskar SG; Agarwal JP; Srinivas C; Dinshaw KA
Expert Rev Anticancer Ther; 2006 Mar; 6(3):405-17. PubMed ID: 16503857
[TBL] [Abstract][Full Text] [Related]
7. Current considerations in multimodality therapy of head and neck cancer.
Sloan DA; McGrath PC; Kenady DE
Clin Plast Surg; 1995 Jan; 22(1):9-19. PubMed ID: 7743713
[TBL] [Abstract][Full Text] [Related]
8. The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients.
Fleming AJ; Johansen ME
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):127-34. PubMed ID: 18327031
[TBL] [Abstract][Full Text] [Related]
9. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
[TBL] [Abstract][Full Text] [Related]
10. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal carcinoma: the impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of the disease.
Manavis J; Sivridis L; Koukourakis MI
Clin Imaging; 2005; 29(2):128-33. PubMed ID: 15752969
[TBL] [Abstract][Full Text] [Related]
12. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
13. [Concomitant radiotherapy and chemotherapy in the treatment of cancers of the upper respiratory and digestive tracts].
Calais G; Le Floch O
Bull Cancer Radiother; 1996; 83(4):321-9. PubMed ID: 9081334
[No Abstract] [Full Text] [Related]
14. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
15. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
16. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
17. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
18. Concomitant chemoradiotherapy for advanced head and neck cancer.
Lin JC; Jan JS; Hsu CY
Jpn J Clin Oncol; 1994 Apr; 24(2):94-100. PubMed ID: 8158863
[TBL] [Abstract][Full Text] [Related]
19. Head and neck cancer: past, present and future.
Chin D; Boyle GM; Porceddu S; Theile DR; Parsons PG; Coman WB
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1111-8. PubMed ID: 16831082
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma.
Amrein PC; Clark JR; Supko JG; Fabian RL; Wang CC; Colevas AD; Posner MR; Deschler DG; Rocco JW; Finkelstein DM; McIntyre JF
Cancer; 2005 Oct; 104(7):1418-27. PubMed ID: 16116597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
